[PMID 16044171] Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations.
[PMID 17033966] Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia.
[PMID 17290445] Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients.
[PMID 17445278] Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings.
[PMID 17888175] Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia.
[PMID 18663367] The dystrobrevin-binding protein 1 gene: features and networks.
[PMID 18715757] Genetic associations with schizophrenia: meta-analyses of 12 candidate genes.
[PMID 18797396] Association study of candidate variants from brain-derived neurotrophic factor and dystrobrevin-binding protein 1 with neuroticism, anxiety, and depression.
[PMID 19631276] Dysbindin modulates brain function during visual processing in children.
[PMID 19884986] Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia.
[PMID 19911060] Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint.
[PMID 21295953] Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers.
[PMID 21639861] Effects of DTNBP1 genotype on brain development in children.
|qualified_impact||Insufficiently evaluated pharmacogenetic|